A Survey of the FDA’s Adverse Event Reporting System Database Concerning Urogenital Tract Infections and Sodium Glucose Cotransporter‐2 Inhibitor Use

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials

(2018) Robert Puckrin et al.   ACTA DIABETOLOGICA

Sodium Glucose Co-Transporter 2 Inhibitors: Beyond Glucose Lowering

(2018) Asli F. Ceylan et al.   CURRENT DRUG TARGETS

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes – A systematic review

(2018) Karin Rådholm et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A systematic review and meta-analysis

(2018) Lin Zhang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Healthcare-associated infections in intensive care units in Taiwan, South Korea, and Japan: recent trends based on national surveillance reports

(2018) Cho-Han Chiang et al.   Antimicrobial Resistance and Infection Control

Summary of the UAA-AAUS guidelines for urinary tract infections

(2017) Hyun-Sop Choe et al.   INTERNATIONAL JOURNAL OF UROLOGY

Prevalence and incidence of urinary tract and genital infections among patients with and without type 2 diabetes

(2017) Gregory A. Nichols et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center

(2017) Yotsapon Thewjitcharoen et al.   Diabetology & Metabolic Syndrome

Global epidemiology of urinary tract infections

(2016) Zafer Tandogdu et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials

(2016) Dandan Li et al.   DIABETES OBESITY & METABOLISM

Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences

(2015) Linda A Gallo et al.   Diabetes & Vascular Disease Research

Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2013) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

The FDA Drug Safety Surveillance Program: Adverse Event Reporting Trends

(2011) Sheila Weiss-Smith   ARCHIVES OF INTERNAL MEDICINE

Biology of Human Sodium Glucose Transporters

(2011) Ernest M. Wright et al.   PHYSIOLOGICAL REVIEWS